• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Merck Commits Nearly $2B for Oral Lipid-Lowering Drug from Chinese Biotech

    BIOSPACE

    Merck Data at ACC.25 Showcases Advancements in Cardiovascular

    BUSINESSWIRE

    Merck`s Biologic Keytruda Receives Approval in US

    FDA

    Merck: Positive Phase 3 Data on Doravirine/Islatravir HIV Regimen

    BUSINESSWIRE

    Merck opens $1B Gardasil manufacturing facility in North Carolina

    BUSINESSWIRE

    Merck’s Injectable Keytruda Create Legal Dispute With Halozyme

    BIOSPACE

    IO Biotech Reports 2024 Business Highlights

    GLOBENEWSWIRE

    Merck nabs $30M from Delaware for potential facility

    FIERCE PHARMA

    Merck expects Keytruda to be part of government price

    REUTERS

    Medicenna Reports MDNA11’s Anti-Cancer Activity at AACR Conference

    GLOBENEWSWIRE

    FDA Grants Review To Merck’s Keytruda Combo For Head & Neck Cancer

    BUSINESSWIRE

    Merck to Participate in the TD Cowen Annual Health Care Conference

    BUSINESSWIRE

    Merck Plans Workforce Expansion in India

    ECONOMICTIMES

    Merck’s Welireg receives European approval for two indications

    PRESS RELEASE

    Radiance rolls into ROR1 race, paying $15M for ADC

    FIERCE BIOTECH

    Merck`s $300M-per-product collab with Epitopea to tumor antigens

    BIOSPACE

    Neuphoria To Receive $15M Milestone Payment From Merck

    GLOBENEWSWIRE

    Kineta sells Genentech, Merck deals to investor ahead of merger

    FIERCE BIOTECH

    Merck reports 2024 sales at $64.2 billion

    INDPHARMAPOST

    BioMed X, Merck Complete ecDNA Cancer Research Project

    CONTRACTPHARMA

    Merck Launches Phase 3 Trial for Zilovertamab Vedotin in DLBCL

    BUSINESSWIRE

    Merck halts Gardasil shipments to China, pulls $11B sales target

    FIERCE PHARMA

    Merck Canada Launches “Listen Close” Campaign for Lung Awareness

    BUSINESSWIRE

    Merck Announces Fourth-Quarter and Full-Year 2024 Financial Results

    BUSINESSWIRE

    Merck Gets Positive CHMP Opinion For CAPVAXIVE In Adults

    BUSINESSWIRE

    Merck Halts Phase 3 HYPERION Trial For WINREVAIR Early

    BUSINESSWIRE

    Merck to stop lung condition drug study early due to strong data

    REUTERS

    Diatech, Merck Expand Collaboration In Middle East, Africa

    BUSINESSWIRE

    FDA Grants Priority Review To Merck’s WELIREG® For PPGL Treatment

    PHARMAWEB

    Merck Announces Q2 2025 Dividend & $10 Billion Share Repurchase

    BUSINESSWIRE

    FDA Grants Priority Review to Merck’s WELIREG for PPGL Treatment

    BUSINESSWIRE

    Merck inaugurates the expansion of its Peenya facility in Bengaluru

    EXPRESSPHARMA

    Merck inaugurates expansion of its Peenya facility in Bengaluru

    EXPRESSPHARMA

    Merck, Eisai combo misses survival goal in GI cancer trial

    FIERCE PHARMA

    Kennedy played key role in Gardasil vaccine case against Merck

    REUTERS

    Merck Sets Q4 And Full-Year 2024 Earnings Call For February 4

    BUSINESSWIRE

    Merck’s GARDASIL® Receives Expanded Approval for Males in China

    BUSINESSWIRE

    Merck`s HPV vaccine gets China approval for amid declining sales

    REUTERS

    WuXi Biologics to sell Irish vaccine site to Merck for $500M

    ENDPTS

    Merck to Participate in the 43rd Annual J.P. Morgan Conference

    BUSINESSWIRE

    Merck wins UK approval for lung disease drug acquired in $11 B deal

    REUTERS

    Merck to discontinue drug for bacterial infection

    REUTERS

    Merck Closes Deal for LM-299 Anti-PD-1/VEGF Bispecific Antibody

    BUSINESSWIRE

    Merck`s HIV combo treatment meets efficacy bar in Ph 3 trials

    FIERCE BIOTECH

    Personalis Advances Strategy with Merck Investment, Moderna Deal

    BUSINESSWIRE

    Merck signs up to $2 bln obesity drug deal with biotech Hansoh

    REUTERS

    Merck discontinues development of 2 experimental cancer drugs

    REUTERS

    Merck Announces FDA Acceptance of Clesrovimab BLA for RSV

    BUSINESSWIRE

    Merck to acquire HUB Organoids to advance cell culture portfolio

    INDPHARMAPOST

    Merck’s KEYTRUDA® Approved in China for NSCLC Neoadjuvant Treatment

    BUSINESSWIRE

    Merck`s WELIREG® Gets EU Nod For VHL Tumors & Advanced RCC

    BUSINESSWIRE

    Keros shares collapse on ‘unanticipated’ setback for lung drug

    BIOPHARMADIVE

    LYNPARZA Demonstrates Prolonged Survival in Early Breast Cancer

    BUSINESSWIRE

    Merck`s Biologic Keytruda Receives Suppl Approval in US

    FDA

    Merck Manuals: What to Know About Listeria and Recent Recalls

    PR NEWSWIRE

    Merck ADC RORs into phase 3 with 100% complete response rate

    PRESS RELEASE

    Merck Announces Ph 3 KEYLYNK-001 Trial Success in Ovarian Cancer

    BUSINESSWIRE

    Merck`s Zilovertamab Vedotin 100% Response in Phase 2 Lymphoma Trial

    BUSINESSWIRE

    Merck & Ridgeback Start Ph 3 Study of LAGEVRIO™ for COVID-19

    BUSINESSWIRE

    Former Merck USA President Joins Klotho Neurosciences

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.